report-bg

India and Neighboring Countries PoC Molecular Diagnostics Market

Segmentation by End User (Hospitals, Clinics, Diagnostic Labs, Research & Academic Institutes, and Others); by Product Type (Kits & Assays, Analyzers, and Software & Services); by Technology Type (PCR, DNA Microarray, Isothermal Amplification, Genetic Sequencing, Hybridization, and Others); and by Application – Demand Analysis & Opportunity Outlook 2019-2026

Buy Now
Report ID: 3168 | Published On: Feb 09, 2023
Request Free Sample Copy
  1. Introduction
    1. Market Definition
    2. Product Overview
    3. Market Segmentation
  2. Research Methodology
    1. Research Objective
    2. Secondary Research
    3. Primary Research
    4. Market Size Estimation
  3. Executive Summary – India and Neighboring Countries PoC Molecular Diagnostic Market
  4. Analysis of Market Dynamics
    1. Drivers
    2. Restraints/Challenges
    3. Trends
    4. Opportunities
  5. Risk Analysis
  6. Impact of COVID-19 on PoC Molecular Diagnostic Market
  7. End-User Usability Analysis
  8. Average Pricing Analysis
  9. India and Neighboring Countries PoC Molecular Diagnostic Market Outlook
    1. Market Size and forecast, 2019-2026F
      1. By Value (USD Million)
    2. PoC Molecular Diagnostic Market Segmentation, 2019-2026F
      1. By End-User
        1. Hospitals, 2019-2026F (USD Million)
        2. Clinics, 2019-2026F (USD Million)
        3. Diagnostic Labs, 2019-2026F (USD Million)
        4. Research & Academic Institutes, 2019-2026F (USD Million)
        5. Others, 2019-2026F (USD Million)
      2. By Product
        1. Kits & Assays, 2019-2026F (USD Million)
        2. Analyzers, 2019-2026F (USD Million)
        3. Software & Services, 2019-2026F (USD Million)
      3. By Technology Type
        1. PCR, 2019-2026F (USD Million)
        2. DNA Microarray, 2019-2026F (USD Million)
        3. Isothermal Amplification, 2019-2026F (USD Million)
        4. Genetic Sequencing, 2019-2026F (USD Million)
        5. Hybridization, 2019-2026F (USD Million)
        6. Other, 2019-2026F (USD Million)
      4. By Application
        1. Respiratory Disease, 2019-2026F (USD Million)
        2. Infectious Disease, 2019-2026F (USD Million)
        3. Oncology, 2019-2026F (USD Million)
        4. STDs, 2019-2026F (USD Million)
        5. Prenatal Testing, 2019-2026F (USD Million)
        6. Hematology, 2019-2026F (USD Million)
        7. Hepatitis, 2019-2026F (USD Million)
        8. Others, 2019-2026F (USD Million)
      5. By Country
        1. India, 2019-2026F (USD Million)
        2. Bangladesh, 2019-2026F (USD Million)
        3. Sri Lanka, 2019-2026F (USD Million)
        4. Nepal, 2019-2026F (USD Million)
        5. Pakistan, 2019-2026F (USD Million)
        6. Maldives, 2019-2026F (USD Million)
  10. India PoC Molecular Diagnostic Market
    1. Market Overview
    2. Market Size, 2019-2026F (USD Million)
    3. Market Segmentation
      1. By End-User
        1. Hospitals, 2019-2026F (USD Million)
        2. Clinics, 2019-2026F (USD Million)
        3. Diagnostic Labs, 2019-2026F (USD Million)
        4. Research & Academic Institutes, 2019-2026F (USD Million)
        5. Others, 2019-2026F (USD Million)
      2. By Product
        1. Kits & Assays, 2019-2026F (USD Million)
        2. Analyzers, 2019-2026F (USD Million)
        3. Software & Services, 2019-2026F (USD Million)
      3. By Technology
        1. PCR, 2019-2026F (USD Million)
        2. DNA Microarray, 2019-2026F (USD Million)
        3. Isothermal Amplification, 2019-2026F (USD Million)
        4. Genetic Sequencing, 2019-2026F (USD Million)
        5. Hybridization, 2019-2026F (USD Million)
        6. Other, 2019-2026F (USD Million)
      4. By Application
        1. Respiratory Disease, 2019-2026F (USD Million)
        2. Infectious Disease, 2019-2026F (USD Million)
        3. Oncology, 2019-2026F (USD Million)
        4. STDs, 2019-2026F (USD Million)
        5. Prenatal Testing, 2019-2026F (USD Million)
        6. Hematology, 2019-2026F (USD Million)
        7. Hepatitis, 2019-2026F (USD Million)
        8. Others, 2019-2026F (USD Million)
        9. Software & Services, 2019-2026F (USD Million)
  11. Bangladesh PoC Molecular Diagnostic Market
    1. Market Overview
    2. Market Size, 2019-2026F (USD Million)
    3. Market Segmentation
      1. By End-User
        1. Hospitals, 2019-2026F (USD Million)
        2. Clinics, 2019-2026F (USD Million)
        3. Diagnostic Labs, 2019-2026F (USD Million)
        4. Research & Academic Institutes, 2019-2026F (USD Million)
        5. Others, 2019-2026F (USD Million)
      2. By Product
        1. Kits & Assays, 2019-2026F (USD Million)
        2. Analyzers, 2019-2026F (USD Million)
        3. Software & Services, 2019-2026F (USD Million)
      3. By Technology
        1. PCR, 2019-2026F (USD Million)
        2. DNA Microarray, 2019-2026F (USD Million)
        3. Isothermal Amplification, 2019-2026F (USD Million)
        4. Genetic Sequencing, 2019-2026F (USD Million)
        5. Hybridization, 2019-2026F (USD Million)
        6. Other, 2019-2026F (USD Million)
      4. By Application
        1. Respiratory Disease, 2019-2026F (USD Million)
        2. Infectious Disease, 2019-2026F (USD Million)
        3. Oncology, 2019-2026F (USD Million)
        4. STDs, 2019-2026F (USD Million)
        5. Prenatal Testing, 2019-2026F (USD Million)
        6. Hematology, 2019-2026F (USD Million)
        7. Hepatitis, 2019-2026F (USD Million)
        8. Others, 2019-2026F (USD Million)
        9. Software & Services, 2019-2026F (USD Million)
  12. Sri Lanka PoC Molecular Diagnostic Market
    1. Market Overview
    2. Market Size, 2019-2026F (USD Million)
    3. Market Segmentation
      1. By End-User
        1. Hospitals, 2019-2026F (USD Million)
        2. Clinics, 2019-2026F (USD Million)
        3. Diagnostic Labs, 2019-2026F (USD Million)
        4. Research & Academic Institutes, 2019-2026F (USD Million)
        5. Others, 2019-2026F (USD Million)
      2. By Product
        1. Kits & Assays, 2019-2026F (USD Million)
        2. Analyzers, 2019-2026F (USD Million)
        3. Software & Services, 2019-2026F (USD Million)
      3. By Technology
        1. PCR, 2019-2026F (USD Million)
        2. DNA Microarray, 2019-2026F (USD Million)
        3. Isothermal Amplification, 2019-2026F (USD Million)
        4. Genetic Sequencing, 2019-2026F (USD Million)
        5. Hybridization, 2019-2026F (USD Million)
        6. Other, 2019-2026F (USD Million)
      4. By Application
        1. Respiratory Disease, 2019-2026F (USD Million)
        2. Infectious Disease, 2019-2026F (USD Million)
        3. Oncology, 2019-2026F (USD Million)
        4. STDs, 2019-2026F (USD Million)
        5. Prenatal Testing, 2019-2026F (USD Million)
        6. Hematology, 2019-2026F (USD Million)
        7. Hepatitis, 2019-2026F (USD Million)
        8. Others, 2019-2026F (USD Million)
        9. Software & Services, 2019-2026F (USD Million)
  13. Nepal PoC Molecular Diagnostic Market
    1. Market Overview
    2. Market Size, 2019-2026F (USD Million)
    3. Market Segmentation
      1. By End-User
        1. Hospitals, 2019-2026F (USD Million)
        2. Clinics, 2019-2026F (USD Million)
        3. Diagnostic Labs, 2019-2026F (USD Million)
        4. Research & Academic Institutes, 2019-2026F (USD Million)
        5. Others, 2019-2026F (USD Million)
      2. By Product
        1. Kits & Assays, 2019-2026F (USD Million)
        2. Analyzers, 2019-2026F (USD Million)
        3. Software & Services, 2019-2026F (USD Million)
      3. By Technology
        1. PCR, 2019-2026F (USD Million)
        2. DNA Microarray, 2019-2026F (USD Million)
        3. Isothermal Amplification, 2019-2026F (USD Million)
        4. Genetic Sequencing, 2019-2026F (USD Million)
        5. Hybridization, 2019-2026F (USD Million)
        6. Other, 2019-2026F (USD Million)
      4. By Application
        1. Respiratory Disease, 2019-2026F (USD Million)
        2. Infectious Disease, 2019-2026F (USD Million)
        3. Oncology, 2019-2026F (USD Million)
        4. STDs, 2019-2026F (USD Million)
        5. Prenatal Testing, 2019-2026F (USD Million)
        6. Hematology, 2019-2026F (USD Million)
        7. Hepatitis, 2019-2026F (USD Million)
        8. Others, 2019-2026F (USD Million)
        9. Software & Services, 2019-2026F (USD Million)
  14. Pakistan PoC Molecular Diagnostic Market
    1. Market Overview
    2. Market Size, 2019-2026F (USD Million)
    3. Market Segmentation
      1. By End-User
        1. Hospitals, 2019-2026F (USD Million)
        2. Clinics, 2019-2026F (USD Million)
        3. Diagnostic Labs, 2019-2026F (USD Million)
        4. Research & Academic Institutes, 2019-2026F (USD Million)
        5. Others, 2019-2026F (USD Million)
      2. By Product
        1. Kits & Assays, 2019-2026F (USD Million)
        2. Analyzers, 2019-2026F (USD Million)
        3. Software & Services, 2019-2026F (USD Million)
      3. By Technology
        1. PCR, 2019-2026F (USD Million)
        2. DNA Microarray, 2019-2026F (USD Million)
        3. Isothermal Amplification, 2019-2026F (USD Million)
        4. Genetic Sequencing, 2019-2026F (USD Million)
        5. Hybridization, 2019-2026F (USD Million)
        6. Other, 2019-2026F (USD Million)
      4. By Application
        1. Respiratory Disease, 2019-2026F (USD Million)
        2. Infectious Disease, 2019-2026F (USD Million)
        3. Oncology, 2019-2026F (USD Million)
        4. STDs, 2019-2026F (USD Million)
        5. Prenatal Testing, 2019-2026F (USD Million)
        6. Hematology, 2019-2026F (USD Million)
        7. Hepatitis, 2019-2026F (USD Million)
        8. Others, 2019-2026F (USD Million)
        9. Software & Services, 2019-2026F (USD Million)
  15. Maldives PoC Molecular Diagnostic Market
    1. Market Overview
    2. Market Size, 2019-2026F (USD Million)
    3. Market Segmentation
      1. By End-User
        1. Hospitals, 2019-2026F (USD Million)
        2. Clinics, 2019-2026F (USD Million)
        3. Diagnostic Labs, 2019-2026F (USD Million)
        4. Research & Academic Institutes, 2019-2026F (USD Million)
        5. Others, 2019-2026F (USD Million)
      2. By Product
        1. Kits & Assays, 2019-2026F (USD Million)
        2. Analyzers, 2019-2026F (USD Million)
        3. Software & Services, 2019-2026F (USD Million)
      3. By Technology
        1. PCR, 2019-2026F (USD Million)
        2. DNA Microarray, 2019-2026F (USD Million)
        3. Isothermal Amplification, 2019-2026F (USD Million)
        4. Genetic Sequencing, 2019-2026F (USD Million)
        5. Hybridization, 2019-2026F (USD Million)
        6. Other, 2019-2026F (USD Million)
      4. By Application
        1. Respiratory Disease, 2019-2026F (USD Million)
        2. Infectious Disease, 2019-2026F (USD Million)
        3. Oncology, 2019-2026F (USD Million)
        4. STDs, 2019-2026F (USD Million)
        5. Prenatal Testing, 2019-2026F (USD Million)
        6. Hematology, 2019-2026F (USD Million)
        7. Hepatitis, 2019-2026F (USD Million)
        8. Others, 2019-2026F (USD Million)
        9. Software & Services, 2019-2026F (USD Million)
  16. Competitive Landscape
    1. F. Hoffmann-La Roche Ltd
    2. Bio-Rad Laboratories, Inc.
    3. Molbio Diagnostics Pvt. Ltd.
    4. bioMerieux SA
    5. Becton, Dickinson and Company
    6. QuantuMDx Group Limited
    7. Beckman Coulter, Inc.
    8. Abbott
    9. MedGenome
    10. Chembio Diagnostics, Inc.
    11. Sysmex Europe GmbH
    12. Cepheid

Growth Drivers and Challenges Impacting the Growth of the India and Neighboring Countries PoC Molecular Diagnostics Market

Growth Drivers

  • Growing Prevalence of Infectious Diseases
  • Increasing Advancements in Healthcare

Challenges

  • Lack of Reimbursement Policies


PoC Molecular Diagnostics Market Graph
Get more information on this report: Request Sample PDF

India and Neighboring Countries PoC Molecular Diagnostics Market Geographical Synopsis
cscs

Geographically, the India and neighboring countries PoC molecular diagnostics market is segmented into India, Bangladesh, Pakistan, Sri-Lanka, Nepal, and Maldives. Amongst the market in these countries, the market in India is anticipated to hold the largest market share throughout the forecast period and further gain a revenue of USD 5323.40 Million by the end of 2026. The market in the country is further anticipated to grow with the highest CAGR of 17.29% during the forecast period. The growth of the market in the country can be attributed to the growing economy and the increasing health expenditure by the government of the nation. In other statistics by the World Bank, the current health expenditure per capita (in current US$) in India, Bangladesh, Pakistan, Sri Lanka, Nepal, and Maldives in the year 2018 was recorded to USD 72.835 thousand, USD 41.909 thousand, USD 42.873 thousand, USD 157.466 thousand, USD 57.847 thousand, and USD 973.537 thousand respectively.

Current Health Expenditure per Capita

Get more information on this reportDownload Sample PDF

The market in the country is also anticipated to grow on account of the numerous health initiatives initiated by the government for the well being of its citizens, and for the growing focus of the nation to develop advanced healthcare resources. The market is also driven by the rising concern for the coronavirus cases in the country, which according to the WHO recorded to be 28,996,473 confirmed cases between the period 3rd of January 2020 and 8th of June 2021.


India and Neighboring Countries PoC Molecular Diagnostics Market Segmentation Synopsis

The India and neighboring countries PoC molecular diagnostics market is segmented on the basis of product type into kits & assays, analyzers, and software & services, out of which, the kits & assays segment in hospitals is anticipated to hold the largest market share throughout the forecast period and generate a revenue of USD 972.21 Million by the end of 2026. In the clinics end user segment, the kits & assays segment is anticipated to gain a market revenue of USD 1431.05 Million by the end of 2026. The market is further segmented by technology type into PCR, DNA microarray, isothermal amplification, genetic sequencing, hybridization, and others, out of which, the PCR segment in the clinics end user segment is anticipated to hold the largest market share and generate a revenue of USD 582.14 Million by the end of 2021. Based on application, the market is segmented into respiratory disease, infectious disease, oncology, STDs, prenatal testing, hematology, hepatitis, and others. Amongst these segments, the infectious disease segment is anticipated to hold the largest market share throughout the forecast period in the diagnostic labs end user segment, and further generate a revenue of USD 91.97 Million by the end of 2026.


Percentage Distribution of Mortality Reported Graph
Get more information on this report: Request Sample PDF

Top Featured Companies Dominating the Market

    Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the India and neighboring countries PoC molecular diagnostics market that are included in our report are F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., Molbio Diagnostics Pvt. Ltd., bioMerieux SA, Becton, Dickinson and Company, QuantuMDx Group Limited, Beckman Coulter, Inc., Abbott, MedGenome, Chembio Diagnostics, Inc., Sysmex Europe GmbH, Cepheid, and others.

    Key Reasons to Buy Our Report

    • The report covers detailed analysis comprising market share attained by each market segment and its sub-segments.

    • It covers market dynamics including growth drivers, trends, potential opportunities, price trend analysis and challenges that impact the market growth.
    • The report includes detailed company profiles of the major players dominating the market.
    • We use effective research methodologies to calculate the market numbers and provide value-added assessment for overall growth.
    • We provide customized reports as per the clients’ requirement helping them to see possible and unexpected challenges and unforeseen opportunities in order to help them reach their goal.

In The News

  • September 1, 2020: F. Hoffmann-La Roche Limited announced that it has launched a SARS-CoV-2 Rapid Antigen Test for use in both symptomatic and asymptomatic people. The test kit provides results in a time span of 15 minutes.


Global Economic Impact

Request Insights
Despite Inflation & Fearing Recession, Businesses Across the Globe Expected to Do Better in 2023:

In 2023, market players might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain.
Controlling Inflation has become the first priority for global economies from last quarter of 2022 and to be followed in 2023. With skewed economic situations, rise in interest rate by governments to control spending and inflation, spiked oil and gas prices, high inflation, geo-political issues including U.S. & China trade war, Russia-Ukraine conflict to intensify the global economic issues.
The interest rates in the U.S. may be less sensitive in 2023 as compared to 2022; sigh of relief for businesses. Positive business sentiments, healthy business balance sheets, growth in construction spending (private construction value in 2022 stood at $1,429.2 billion, 11.7 percent (±1.0 percent) above the $1,279.5 billion spent in 2021, Residential construction in 2022 was $899.1 billion, up by 13.3 percent (±2.1 percent) from $793.7 billion in 2021, non-residential construction touched $530.1 billion, 9.1 percent (±1.0 percent) above the $485.8 billion in 2021.) showcases minimal impact of recession in the country.
Similarly, spiked spending in the European and major Asia economics including, India, China & Japan to showcase less impact on the global demand.

Key Questions Answered in the Report

1) What are the major factors driving the growth of the India and Neighboring countries PoC molecular diagnostics market?

Ans: The increasing prevalence of infectious diseases, along with the rising advancements in healthcare are some of the major factors anticipated to drive the growth of the market.

2) What would be the CAGR of India and Neighboring countries PoC molecular diagnostics market over the forecast period?

Ans: The market is anticipated to attain a CAGR of 16.34% over the forecast period, i.e., 2021-2026.

3) What are the challenges affecting the India and Neighboring countries PoC molecular diagnostics market growth?

Ans: The lack of reimbursement policies is one of the major factors estimated to hamper the market growth.

5) Who are the major players dominating the India and Neighboring countries PoC molecular diagnostics market?

Ans: The major players in the market are F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., Molbio Diagnostics Pvt. Ltd., Beckman Coulter, Inc., Abbott, MedGenome, Chembio Diagnostics, Inc., Sysmex Europe GmbH, Cepheid, and others.

6) How are the company profiles selected?

Ans: The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

7) What are the segments in the India and neighboring countries PoC molecular diagnostics market?

Ans: The market is segmented by end user, product type, technology type, application and by country.

Let Us Hear About Your Requirements:

Submit Your Request For Proposal (RFP)

Request Research Report Sample